MINCR is a MYC-induced lncRNA able to modulate MYC's transcriptional network in Burkitt lymphoma cells

Proceedings of the National Academy of Sciences of the United States of America

Volumn 112, Issue 38, 2015, Pages E5261-E5270

  Doose, Gero ^a   Haake, Andrea ^b   Bernhart, Stephan H ^a   López, Cristina ^b   Duggimpudi, Sujitha ^c   Wojciech, Franziska ^b   Bergmann, Anke K ^b,d   Borkhardt, Arndt ^c   Burkhardt, Birgit ^e,f   Claviez, Alexander ^d   Dimitrova, Lora ^g   Haas, Siegfried ^h   Hoell, Jessica I ^c   Hummel, Michael ^g   Karsch, Dennis ^d   Klapper, Wolfram ^b   Kleo, Karsten ^g   Kretzmer, Helene ^a   Kreuz, Markus ^a   Küppers, Ralf ⁱ   Lawerenz, Chris ^j   Lenze, Dido ^g   Loeffler, Markus ^a   Mantovani Löffler, Luisa ^k   Möller, Peter ^l   Ott, German ^m   Richter, Julia ^b   Rohde, Marius ^f   Rosenstiel, Philip ^b   Rosenwald, Andreas ⁿ   Schilhabel, Markus ^b   Schneider, Markus ⁱ   Scholz, Ingrid ^j   Stilgenbauer, Stephan ^l   Stunnenberg, Hendrik G ^o   Szczepanowski, Monika ^b   Trümper, Lorenz ^p   Weniger, Marc A ⁱ   Hoffmann, Steve ^a   Siebert, Reiner ^b   Iaccarino, Ingram ^b,q   Eisenman, Robert N ^r   more..

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

^c UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^d UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^e UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^f UNIVERSITY HOSPITAL GIESSEN   (Germany)

^g CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^h Friedrich Ebert Krankenhaus   (Germany)

ⁱ UNIVERSITY OF DUISBURG ESSEN   (Germany)

^j GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^k Klinikum St Georg   (Germany)

^l UNIVERSITY OF ULM   (Germany)

^m ROBERT BOSCH HOSPITAL   (Germany)

ⁿ UNIVERSITY OF WÜRZBURG   (Germany)

^o RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^p UNIVERSITY OF GÖTTINGEN   (Germany)

^q INSTITUTE OF GENETICS AND BIOPHYSICS ADRIANO BUZZATI TRAVERSO   (Italy)

^r Fred Hutchinson Cancer Research Center   (United States)

more..

Author keywords

B cell lymphoma; Cell cycle; LncRNA; MYC

Indexed keywords

AURORA KINASE; DNA REPLICATION FACTOR 1; LONG UNTRANSLATED RNA; MINCR PROTEIN; MYC PROTEIN; NUCLEIC ACID BINDING PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; CHROMATIN;

ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; BINDING SITE; BURKITT LYMPHOMA; BURKITT LYMPHOMA CELL LINE; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CELL VIABILITY; CHROMATIN; CONTROLLED STUDY; GENE EXPRESSION; GENE FUNCTION; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOMA CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; RECEPTOR DOWN REGULATION; RNA INTERFERENCE; TRANSCRIPTOMICS; CELL CYCLE; CELL LINE; CELL SURVIVAL; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; METABOLISM; MOLECULAR GENETICS; NEOPLASM; NUCLEOTIDE SEQUENCE; SEQUENCE HOMOLOGY; TUMOR CELL LINE;

BASE SEQUENCE; BINDING SITES; BURKITT LYMPHOMA; CELL CYCLE; CELL LINE; CELL LINE, TUMOR; CELL SURVIVAL; CHROMATIN; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPHOMA, B-CELL; MOLECULAR SEQUENCE DATA; NEOPLASMS; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS C-MYC; RNA, LONG NONCODING; RNA, SMALL INTERFERING; SEQUENCE HOMOLOGY, NUCLEIC ACID;

EID: 84943169574     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1505753112     Document Type: Article

References (72)

1. Dalla-Favera R, et al (1982) Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc Natl Acad Sci USA 79(24):7824-7827.
2. Hecht JL, Aster J.C. (2000) Molecular biology of Burkitt's lymphoma. J Clin Oncol 18(21): 3707-3721.
3. Molyneux EM, et al (2012) Burkitt's lymphoma. Lancet 379(9822):1234-1244.
4. Felsher DW, Bishop J.M. (1999) Reversible tumorigenesis by MYC in hematopoietic lineages. Mol Cell 4(2):199-207.
5. Boxer LM, Dang C.V. (2001) Translocations involving c-myc and c-myc function. Oncogene 20(40):5595-5610.
6. Nesbit CE, Tersak JM, Prochownik E.V. (1999) MYC oncogenes and human neoplastic disease. Oncogene 18(19):3004-3016.
7. Beroukhim R, et al (2010) The landscape of somatic copy-number alteration across human cancers. Nature 463(7283):899-905.
8. Fernandez PC, et al (2003) Genomic targets of the human c-Myc protein. Genes Dev 17(9):1115-1129.
9. Li Z, et al (2003) A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells. Proc Natl Acad Sci USA 100(14):8164-8169.
10. McMahon SB, Van Buskirk HA, Dugan KA, Copeland TD, Cole M.D. (1998) The novel ATM-related protein TRRAP is an essential cofactor for the c-Myc and E2F oncoproteins. Cell 94(3):363-374.
11. Zhang N, et al (2014) MYC interacts with the human STAGA coactivator complex via multivalent contacts with the GCN5 and TRRAP subunits. Biochim Biophys Acta 1839(5):395-405.
12. Frank SR, et al (2003) MYC recruits the TIP60 histone acetyltransferase complex to chromatin. EMBO Rep 4(6):575-580.
13. Rahl PB, et al (2010) c-Myc regulates transcriptional pause release. Cell 141(3):432-445.
14. Lin CY, et al (2012) Transcriptional amplification in tumor cells with elevated c-Myc. Cell 151(1):56-67.
15. Nie Z, et al (2012) c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells. Cell 151(1):68-79.
16. Sabò A, et al. (2014) Selective transcriptional regulation by Myc in cellular growth control and lymphomagenesis. Nature 511(7510):488-492.
17. Walz S, et al (2014) Activation and repression by oncogenic MYC shape tumour-specific gene expression profiles. Nature 511(7510):483-487.
18. Carninci P, et al; FANTOM Consortium; RIKEN Genome Exploration Research Group and Genome Science Group (Genome Network Project Core Group) (2005) The transcriptional landscape of the mammalian genome. Science 309(5740):1559-1563.
19. Mattick JS, Makunin I.V. (2006) Non-coding RNA. Hum Mol Genet 15(Spec No 1):R17-R29.
20. Djebali S, et al (2012) Landscape of transcription in human cells. Nature 489(7414): 101-108.
21. Huarte M, et al (2010) A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell 142(3):409-419.
22. Prensner JR, et al (2011) Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression. Nat Biotechnol 29(8):742-749.
23. Flockhart RJ, et al (2012) BRAFV600E remodels the melanocyte transcriptome and induces BANCR to regulate melanoma cell migration. Genome Res 22(6):1006-1014.
24. Sauvageau M, et al (2013) Multiple knockout mouse models reveal lincRNAs are required for life and brain development. eLife 2:e01749.
25. Holdt LM, et al (2013) Alu elements in ANRIL non-coding RNA at chromosome 9p21 modulate atherogenic cell functions through trans-regulation of gene networks. PLoS Genet 9(7):e1003588.
26. Esteller M (2011) Non-coding RNAs in human disease. Nat Rev Genet 12(12):861-874.
27. Derrien T, et al (2012) The GENCODE v7 catalog of human long noncoding RNAs: Analysis of their gene structure, evolution, and expression. Genome Res 22(9):1775-1789.
28. Borsani G, et al (1991) Characterization of a murine gene expressed from the inactive X chromosome. Nature 351(6324):325-329.
29. Lee JT, Lu N, Han Y. (1999) Genetic analysis of the mouse X inactivation center defines an 80-kb multifunction domain. Proc Natl Acad Sci USA 96(7):3836-3841.
30. Kretz M, et al (2012) Suppression of progenitor differentiation requires the long noncoding RNA ANCR. Genes Dev 26(4):338-343.
31. Yang L, et al (2011) ncRNA- and Pc2 methylation-dependent gene relocation between nuclear structures mediates gene activation programs. Cell 147(4):773-788.
32. Bond CS, Fox A.H. (2009) Paraspeckles: Nuclear bodies built on long noncoding RNA. J Cell Biol 186(5):637-644.
33. Rinn JL, et al (2007) Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 129(7):1311-1323.
34. Tsai M-C, et al (2010) Long noncoding RNA as modular scaffold of histone modification complexes. Science 329(5992):689-693.
35. Alizadeh AA, et al (2000) Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403(6769):503-511.
36. Hummel M, et al; Molecular Mechanisms in Malignant Lymphomas Network Project of the Deutsche Krebshilfe (2006) A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. N Engl J Med 354(23):2419-2430.
37. Dave SS, et al; Lymphoma/Leukemia Molecular Profiling Project (2006) Molecular diagnosis of Burkitt's lymphoma. N Engl J Med 354(23):2431-2442.
38. Alfano D, et al (2010) Modulation of cellular migration and survival by c-Myc through the downregulation of urokinase (uPA) and uPA receptor. Mol Cell Biol 30(7):1838-1851.
39. Pocsfalvi G, et al (2011) Analysis of secretome changes uncovers an autocrine/paracrine component in the modulation of cell proliferation and motility by c-Myc. J Proteome Res 10(12):5326-5337.
40. Schuhmacher M, et al (1999) Control of cell growth by c-Myc in the absence of cell division. Curr Biol 9(21):1255-1258.
41. Yustein JT, et al (2010) Induction of ectopic Myc target gene JAG2 augments hypoxic growth and tumorigenesis in a human B-cell model. Proc Natl Acad Sci USA 107(8): 3534-3539.
42. Seitz V, et al (2011) Deep sequencing of MYC DNA-binding sites in Burkitt lymphoma. PLoS One 6(11):e26837.
43. Rosenbloom KR, et al (2013) ENCODE data in the UCSC Genome Browser: Year 5 update. Nucleic Acids Res 41(Database issue):D56-D63.
44. Cabili MN, et al (2011) Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev 25(18):1915-1927.
45. Aukema SM, et al; Molecular Mechanisms in Malignant Lymphomas Network Project (2014) Biological characterization of adult MYC-translocation-positive mature B-cell lymphomas other than molecular Burkitt lymphoma. Haematologica 99(4):726-735.
46. Stellas D, et al (2014) Therapeutic effects of an anti-Myc drug on mouse pancreatic cancer. J Natl Cancer Inst 106(12):106.
47. Ischenko I, Petrenko O, Hayman M.J. (2014) Analysis of the tumor-initiating and metastatic capacity of PDX1-positive cells from the adult pancreas. Proc Natl Acad Sci USA 111(9):3466-3471.
48. Lee JT, Jaenisch R. (1997) The (epi)genetic control of mammalian X-chromosome inactivation. Curr Opin Genet Dev 7(2):274-280.
49. Trimarchi T, et al (2014) Genome-wide mapping and characterization of Notch-regulated long noncoding RNAs in acute leukemia. Cell 158(3):593-606.
50. Gupta RA, et al (2010) Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 464(7291):1071-1076.
51. Liu X, Li D, Zhang W, Guo M, Zhan Q. (2012) Long non-coding RNA gadd7 interacts with TDP-43 and regulates Cdk6 mRNA decay. EMBO J 31(23):4415-4427.
52. Carrieri C, et al (2012) Long non-coding antisense RNA controls Uchl1 translation through an embedded SINEB2 repeat. Nature 491(7424):454-457.
53. Salaverria I, et al; Molecular Mechanisms in Malignant Lymphoma Network Project; Berlin-Frankfurt-Münster Non-Hodgkin Lymphoma Group (2014) A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma. Blood 123(8):1187-1198.
54. Richter J, et al; ICGC MMML-Seq Project (2012) Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing. Nat Genet 44(12):1316-1320.
55. Hart JR, Roberts TC, Weinberg MS, Morris KV, Vogt P.K. (2014) MYC regulates the non-coding transcriptome. Oncotarget 5(24):12543-12554.
56. Kim T, et al (2015) Role of MYC-regulated long noncoding RNAs in cell cycle regulation and tumorigenesis. J Natl Cancer Inst 107(4):107.
57. Kim T, et al (May 11, 2015) MYC-repressed long noncoding RNAs antagonize MYC-induced cell proliferation and cell cycle progression. Oncotarget.
58. Winkle M, et al (2015) Long noncoding RNAs as a novel component of the Myc transcriptional network. FASEB J 29(6):2338-2346.
59. Hung C-L, et al (2014) A long noncoding RNA connects c-Myc to tumor metabolism. Proc Natl Acad Sci USA 111(52):18697-18702.
60. Ullius A, et al (2014) The interaction of MYC with the trithorax protein ASH2L promotes gene transcription by regulating H3K27 modification. Nucleic Acids Res 42(11): 6901-6920.
61. Yang YW, et al (2014) Essential role of lncRNA binding for WDR5 maintenance of active chromatin and embryonic stem cell pluripotency. eLife 3:e02046.
62. Liu D, et al (2014) Sine oculis homeobox homolog 1 promotes DNA replication and cell proliferation in cervical cancer. Int J Oncol 45(3):1232-1240.
63. Yang D, et al (2010) Therapeutic potential of a synthetic lethal interaction between the MYC proto-oncogene and inhibition of aurora-B kinase. Proc Natl Acad Sci USA 107(31):13836-13841.
64. Seo J, et al (2005) Cdt1 transgenic mice develop lymphoblastic lymphoma in the absence of p53. Oncogene 24(55):8176-8186.
65. Hoffmann S, et al (2009) Fast mapping of short sequences with mismatches, insertions and deletions using index structures. PLOS Comput Biol 5(9):e1000502.
66. Hoffmann S, et al (2014) A multi-split mapping algorithm for circular RNA, splicing, trans-splicing and fusion detection. Genome Biol 15(2):R34.
67. Lee TI, Johnstone SE, Young R.A. (2006) Chromatin immunoprecipitation and micro-array-based analysis of protein location. Nat Protoc 1(2):729-748.
68. Haralambieva E, Kleiverda K, Mason DY, Schuuring E, Kluin P.M. (2002) Detection of three common translocation breakpoints in non-Hodgkin's lymphomas by fluorescence in situ hybridization on routine paraffin-embedded tissue sections. J Pathol 198(2):163-170.
69. Martin M (2011) Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet J 17(1):10-12.
70. Breese MR, Liu Y. (2013) NGSUtils: A software suite for analyzing and manipulating next-generation sequencing datasets. Bioinformatics 29(4):494-496.
71. Anders S, Huber W. (2010) Differential expression analysis for sequence count data. Genome Biol 11(10):R106.
72. Bailey TL, et al (2009) MEME SUITE: Tools for motif discovery and searching. Nucleic Acids Res 37(Web Server issue):W202-W208.